000			02021 a2200577 4500
005			20250515134423.0
264		0	_c20090211
008			200902s 0 0 eng d
022			_a1744-6872
024	7		_a10.1097/FPC.0b013e32830e1e16 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmith, Helen E
245	0	0	_aRole of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. _h[electronic resource]
260			_bPharmacogenetics and genomics _cNov 2008
300			_a943-53 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_a8,11,14-Eicosatrienoic Acid _xanalogs & derivatives
650	0	4	_aArachidonic Acid _xmetabolism
650	0	4	_aAryl Hydrocarbon Hydroxylases _xgenetics
650	0	4	_aCalcineurin Inhibitors
650	0	4	_aCyclosporine _xadverse effects
650	0	4	_aCytochrome P-450 CYP2C8
650	0	4	_aCytochrome P-450 CYP2J2
650	0	4	_aCytochrome P-450 Enzyme System _xgenetics
650	0	4	_aDemography
650	0	4	_aFemale
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aKidney Failure, Chronic _xchemically induced
650	0	4	_aKidney Function Tests
650	0	4	_aKidney Transplantation
650	0	4	_aKinetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aTacrolimus _xadverse effects
650	0	4	_aUnited States _xepidemiology
700	1		_aJones, J P
700	1		_aKalhorn, Thomas F
700	1		_aFarin, Federico M
700	1		_aStapleton, Patricia L
700	1		_aDavis, Connie L
700	1		_aPerkins, James D
700	1		_aBlough, David K
700	1		_aHebert, Mary F
700	1		_aThummel, Kenneth E
700	1		_aTotah, Rheem A
773	0		_tPharmacogenetics and genomics _gvol. 18 _gno. 11 _gp. 943-53
856	4	0	_uhttps://doi.org/10.1097/FPC.0b013e32830e1e16 _zAvailable from publisher's website
999			_c18239309 _d18239309